How Can You Improve Adult Immunization? Strategies for Community Healthcare Professionals

by Michael Fenimore | Dec 3, 2025 | Dentist, Pharmacy, Physician Associate/Assistant, Psychiatry, Pulmonology

Do you work with clients or patients to restore good physical or oral health, help develop coping skills and support emotional well-being, provide education about medications, relieve pain, or promote good nutrition and fitness?

Community Deployment of Bispecific Antibodies in Multiple Myeloma & Non-Hodgkin Lymphoma within RWJBarnabas Health/Rutgers Cancer Institute

by Michael Fenimore | Dec 3, 2025 | Emergency Medicine, Hematology-Oncology, Oncology, Pharmacy

This curriculum is designed to address the operational, clinical, and logistical challenges of integrating bispecific antibody (bsAb) therapies across the RWJBarnabas Health system.

Multidisciplinary Collaboration and Education: Learning to Recognize and Manage the Patient with AATD-LD

by Michael Fenimore | Dec 3, 2025 | Allergy and Immunology, Family Medicine, Gastroenterology, Hepatology, Internal Medicine, Pulmonology

Given the alarmingly high rate of underdiagnosis and the wide clinical variability of liver manifestations, it is critical to advance the management of patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (AATD-LD).

On the front lines – Managing CRS in the Emergency Department

by Michael Fenimore | Dec 3, 2025 | Emergency Medicine, Oncology

Rigorous clinical research has led to the discovery of novel immunologic therapies. Chimeric antigen receptor T cell (CAR T-cell) therapy has shown impressive outcomes but is associated with a significant risk of adverse events (AEs), chiefly cytokine release syndrome...

Addressing the Challenges in the Multidisciplinary Care of Patients with High-Risk NMSC

by Michael Fenimore | Dec 3, 2025 | Dermatology, Oncology

Non-melanoma skin cancers (NMSC) represent a class of heterogeneous cutaneous malignancies including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), Merkel cell carcinoma (MCC), and rarer skin cancers.